is metformin a glp-1 receptor agonist New aspects of an old drug: as glucagon-like peptide 1 (GLP-1) enhancer and sensitiser | Diabetologia What Next When Metformin Isn't

When asked about whether they expected the Trump administrations policies to lower the cost of prescription drugs for people like them, most (62%) say it is either not too likely or not at all likely, while nearly four in 10 (38%) say it is very or somewhat likely. Those expectations are largely driven by partisanship

doi: 10.1210/endo.133.1.8319572 [DOI] [PubMed] [Google Scholar] 47

Each comes with its own dosing and indications

Researchers noted that people receiving the medication experienced statistically significant and clinically meaningful weight loss starting at 28 weeks

Theres also a lot less maintenance with the shot